LEO Pharma Products in Australia

All LEO Pharma products in Australia must be prescribed or administered by a healthcare professional.

To view the Product Information (PI) or Consumer Medicine Information (CMI), click the underlined hyperlinks below the product names.

If you are visiting this site from New Zealand the relevant Data Sheet and Consumer Medicine Information for these products are available at www.medsafe.govt.nz

 Dermatology

  • Enstilar® Foam Spray – calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g foam spray (aerosol can)*

                      PI                 CMI

             *Enstilar® is not currently marketed in New Zealand

 

  •  Daivobet® 50/500 gel - calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g gel (bottle)

                   PI                  CMI   
         

  • Daivobet® 50/500 ointment - calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g ointment (tube) 

                   PI                 CMI            

 

  • Picato® gel - ingenol mebutate 0.015% and ingenol mebutate 0.05% gel (tube)        

                  PI                  CMI - Picato® gel 0.015%          CMI - Picato® gel 0.05%
        

  • Daivonex® cream - calcipotriol 50 microgram/g cream (tube)

Dear Healthcare Professional, Daivonex® Cream is currently experiencing a global shortage due to the lack of availability of one of the excipients in the formulation of the cream. LEO Pharma has submitted an application to the TGA for a reformulated product, and is working to make this reformulated product available in Australia. For further information about this shortage, please refer to the TGA's Medicines Shortage website: Calcipotriol - TGA Medicines Shortage listing  

                   PI               CMI  
    

  • Daivonex® scalp solution - calcipotriol 50 microgram/mL solution (bottle) - (Please note: this product was delisted from the PBS on 1st September 2012 and the product has been subsequently discontinued in Australia)


                   PI                 CMI          

 

  • Advantan® cream - methylprednisolone​ aceponate 1mg/g (0.1%) (cream tube)​
  • Advantan® lotion - methylprednisolone aceponate 0.1% (lotion tube​)

  • Advantan® fatty ointment - methylprednisolone​ aceponate 1mg/g (0.1%) (fatty ointment tube​)

  • Advantan® ointment - methylprednisolone​ aceponate 1mg/g (0.1%) (ointment tube)


                   PI                 CMI      

          

  • Finacea® gel - azelaic acid 150 mg/g (15%) (gel tube)​

  • Fucidin® Tablets - sodium fusidate 250mg (tablet)

PI                 CMI   

 

  • Fucidin® Ointment – fucidic acid 2% (ointment tube)​

PI                 CMI 

 

  • Scheriproct® ointment​ – cinchocaine hydrochloride 5mg/g and prednisolone hexanoate 1.9mg/g (ointment tube)
     
  • Scheriproct® suppositories – cinchocaine hydrochloride 1mg and prednisolone hexanoate 1.3mg (suppository strip)

PI                 CMI